The relationship between vitamin D serum level and 2 year disease free survival of breast cancer

Document Type : Original Article

Authors

1 Associate Professor, Department of Radio-Oncology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

2 Professor, Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

3 Assistant Professor, Department of Obstetrics and of Gynecology, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnord, Iran.

4 Resident, Department of Obstetrics and Gynecology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Abstract

Introduction: From past time, breast cancer has been one of clinical and common problems among women. Given that chronic vitamin D deficiency is prevalent among most Iranian women, this study was performed with aim to examine the relationship between vitamin D serum level and 2 year survival without incidents such as metastasis and death among patients with breast cancer. 
Methods: This cross-sectional retrospective study was performed on 360 patients with non-metastatic breast cancer in 2012-2017. Data collection tool was checklist. Serum levels of vitD were measured in early of breast cancer diagnosis before the start of non-surgical therapy (radio-oncology). The effects of vitD level on two year disease free survival was compared among patients with vitD deficiency and those with normal level of VitD. Data was analyzed by SPSS software (version 16) and Copplan and logRank tests and Chi-square test. PResults: 2year disease free survival was 91.3%. No significant difference was observed in 2year disease free survival between patients with vitD deficiency and those with normal level of VitD (p=0.313). However, survival time was higher in people with normal vitD serum levels, but this difference was not statistically significant (p>0.05).
Conclusion: Although the results of current study did not show significant relationship between the effect of vitD level and disease free survival, but the number of good prognosis was more in patients with normal serum levels than those with low levels that indicates the clinical value.

Keywords


  1. Breasted JH. The Edwin smith surgical papyrus. Chicago, Illinois: The University Chicago Press; 1930.
  2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65(2):87-108.
  3. Siegel RL, Miller KD, Jemal A. Cancer statistics. CA Cancer J Clin 2017; 67(1):7-30.
  4. Fouladi N, Amani F, Harghi AS, Nayebyazdi N. Five year survival of women with breast cancer in Ardabil, north-west of Iran. Asian Pac J Cancer Prev 2011; 12(7):1799-801.
  5. Naieni KH, Ardalan A, Mahmoodi M, Motevalian A, Yahyapoor Y, Yazdizadeh B. Risk factors of breast cancer in north of Iran: a case-control in Mazandaran province. Asian Pac J Cancer Prev 2007; 8(3):395-8.
  6. Ghiasvand R, Maram ES, Tahmasebi S, Tabatabaee SH. Risk factors for breast cancer among young women in southern Iran. Int J Cancer 2011; 129(6):1443-9.
  7. Anderson LN, Cotterchio M, Vieth R, Knight JA. Vitamin D and calcium intakes and breast cancer risk in pre- and postmenopausal women. Am J Clin Nutr 2010; 91(6):1699-707.
  8. Peppone LJ, Huston AJ, Reid ME, Rosier RN, Zakharia Y, Trump DL, et al. The effect of various vitamin D supplementation regimens in breast cancer patients. Breast Cancer Res Treat 2011; 127(1):171-7.
  9. Anderson LN, Cotterchio M, Cole DE, Knight JA. Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario. Cancer Epidemiol Biomarkers Prev 2011; 20(8):1708-17.
  10. Engel P, Fagherazzi G, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F. Joint effects of dietary vitamin D and sun exposure on breast cancer risk: results from the French E3N cohort. Cancer Epidemiol Biomarkers Prev 2011; 20(1):187-98.
  11. Engel P, Fagherazzi G, Boutten A, Dupre T, Mesrine S, Boutron-Ruault MC, et al. Serum 25(OH) vitamin D and risk of breast cancer: a nested case-control study from the French E3N cohort. Cancer Epidemiol Biomarkers Prev 2010; 19(9):2341-50.
  12. Amadori D, Serra P, Masalu N, Pangan A, Scarpi E, Bugingo AM, et al. Vitamin D receptor polymorphisms or serum levels as key drivers of breast cancer development? The question of the vitamin D pathway. Oncotarget 2017; 8(8):13142-56.
  13. Chlebowski RT. Vitamin D and breast cancer: interpreting current evidence. Breast Cancer Res 2011; 13(4):217.
  14. Kawase T, Matsuo K, Suzuki T, Hirose K, Hosono S, Watanabe M, et al. Association between vitamin D and calcium intake and breast cancer risk according to menopausal status and receptor status in Japan. Cancer Sci 2010; 101(5):1234-40.
  15. Lee MS, Huang YC, Wahlqvist ML, Wu TY, Chou YC, Wu MH, et al. Vitamin D decreases risk of breast cancer in premenopausal women of normal weight in subtropical Taiwan. J Epidemiol 2011; 21(2):87-94.
  16. Kuper H, Yang L, Sandin S, Lof M, Adami HO, Weiderpass E. Prospective study of solar exposure, dietary vitamin D intake, and risk of breast cancer among middle-aged women. Cancer Epidemiol Biomarkers Prev 2009; 18(9):2558-61.
  17. Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, et al. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 2008; 100(22):1581-91.
  18. Moorman PG, Terry PD. Consumption of dairy products and the risk of breast cancer: a review of the literature. Am J Clin Nutr 2004; 80(1):5-14.
  19. Al Sarakbi W, Salhab M, Mokbel K. Dairy products and breast cancer risk: a review of the literature. Int J Fertil Womens Med 2005; 50(6):244-9.
  20. Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 2009; 27(23):3757-63.
  21. Vrieling A, Hein R, Abbas S, Schneeweiss A, Flesch-Janys D, Chang-Claude J. Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study. Breast Cancer Res 2011; 13(4):R74.
  22.  Kim HJ, Lee YM, Ko BS, Lee JW, Yu JH, Son BH, et al. Vitamin D deficiency is correlated with poor outcomes in patients with luminal-type breast cancer. Ann Surg Oncol 2011; 18(7):1830-6.
  23. Crew KD, Gammon MD, Steck SE, Hershman DL, Cremers S, Dworakowski E, et al. Association between plasma 25-hydroxyvitamin D and breast cancer risk. Cancer Prev Res (Phila) 2009; 2(6):598-604.